New Algorithm Speeds the Hunt for Nature-Derived Antibiotics and Cancer Drugs

Last week, Scientific American reported on the decline of nature-derived compounds in the pharmaceutical pipeline, in part because of the cost of isolating and identifying compounds that may have already been described and are therefore not patentable. [More]

Read the whole article on Scientific American

More from Scientific American